JUPITER NEUROSCIENCES, INC.
JUNS · XNASCIK 1679628fmd_1FKPBVBFXG7T3ZTK66K73343A4Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Jun 30, 2026, 14 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | – | 0 | 0 |
| Cost of revenue | – | – | 0 |
| Gross profit | – | – | 0 |
| Research and development | 1 | 0 | 2 |
| Selling, general and administrative | – | – | 7 |
| Total operating expenses | 4 | 3 | 9 |
| Operating income | (4) | (3) | (9) |
| Interest expense | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | – |
| Other non-operating income (expense) | (1) | 1 | 0 |
| Net income | (5) | (2) | (9) |